★★★★★ 5
As shown...
Format: Paperback
As shown...
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 5, 2025
glp-1 for alcohol use disorder Emerging pharmacological targets for alcohol use disorder
Marsoni
M251S
Get it in 3 business days with 1 day shipping.
Friday, May 29
Employers Grapple With GLP 1 Coverage for Weight Loss Ogletree Compare GLP 1 Options Ozempic v Mounjaro WeightWatchers WW USA GLP 1 RAs: WHO endorse weight loss drugs for obesity control Relative effects of glucagon like peptide 1 (GLP 1) agonists vs Download Scientific Diagram
Quick Dispatch:
Your glp-1 for alcohol use disorder Emerging pharmacological targets for alcohol use disorder orders ship within 1-2 business days.
Delivery Options:
- Standard: 3-7 business days
- Fast: 2-3 business days
- Express: 1-2 business days
Order Tracking:
You'll receive a tracking link by email once your glp-1 for alcohol use disorder Emerging pharmacological targets for alcohol use disorder ships.
Need Help?
Questions about glp-1 for alcohol use disorder Emerging pharmacological targets for alcohol use disorder, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 for alcohol use disorder Emerging pharmacological targets for alcohol use disorder in your area.
Get Shipping Estimates
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
Wegovy and Ozempic (semaglutide) are associated with a 50-56% reduction in alcohol addiction
20.75
Possible mechanisms by which GLP-1 may reduce alcohol consumption. (A)
24.40
IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
23.06
Medscape | Once weekly semaglutide injections reduced alcohol consumption in patients with alcohol use disorder and comorbid obesity. Results of the
21.47
GLP-1 RAs may reduce alcohol-related hospitalization risk
21.69
GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer
27.76
GLP-1 Agonists for Alcohol Use Disorder: UK Evidence and Guidance
25.53
4.2 ★★★★★
Based on 109 reviews
Sort
Product Reviews
★★★★★ 5
Good book
Format: Paperback
Already a med surg nurse but needed a refresher for the certification test. Honestly just skimmed through this and pass the test
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 19, 2024
★★★★★ 5
Great series
Format: Paperback
This does not disappoint. We buy the new editions as they are published to stay current with this series which is written in clear, understandable words.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 24, 2022
★★★★★ 1
Not US
Format: Paperback
Not fir US students
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 28, 2025
★★★★★ 2
It's not that helpful.
Format: Paperback
Has the usual information and isn't even broken down to be easier to retain
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 27, 2024
recommand products
GLP-1 Patches
25.81
GLP-1 Support Premium Patch Pack by PatchAid
24.61
Can GLP-1 Drugs Aid Multiple Sclerosis Management?
27.49
GLP-1 drugs like Ozempic are proving effective in a variety of applications beyond managing diabetes and weight loss. On Real Talk MS, Dr. Ellen Mowry shares early findings from a clinical trial
27.42
GLP-1 Patches': Do the Products Influencers Are Selling Work?
28.41